Danxi Geng

机构：First Hospital of China Medical University, China Medical University · ORCID：0009-0005-7954-6800

发表论文 26 篇 · 总被引 902 次 · h-index 10

代表论文

• α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure (2023 · Cell Research · 被引 279)
• Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial (2023 · The Lancet · 被引 141)
• The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches (2023 · Basic Research in Cardiology · 被引 103)
• Advances in the study of exosomes in cardiovascular diseases (2023 · Journal of Advanced Research · 被引 82)
• Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches (2024 · Pharmacological Research · 被引 62)
• Hyperlipidemia and hypertension have synergistic interaction on ischemic stroke: insights from a general population survey in China (2022 · BMC Cardiovascular Disorders · 被引 45)